Abstract
The study of the Urocortin family of peptides is becoming increasingly important clinically, as new discoveries have revealed that their roles in the body are extremely diverse. They range from being involved in the aetiology of affective disorders, boosting the immune system, to cardioprotection during ischaemia and reperfusion injury. Therefore, it is important to understand how these peptides become activated, how they activate different cell types and finally their intracellular signalling pathways. Such studies may enable scientists to develop clinical therapies based on their mechanism of action, which may be used to alleviate a diverse range of pathologies.
Keywords: Corticotrophin-releasing hormone, Urocortin, cardiac ischaemia and reperfusion injury, Affymetrix gene chip microarrays, affective disorders, cardiomyocyte mitochondria
Mini-Reviews in Medicinal Chemistry
Title: The Urocortins: Mechanisms of Cardioprotection and Therapeutic Potential
Volume: 6 Issue: 10
Author(s): K. M. Lawrence and D. S. Latchman
Affiliation:
Keywords: Corticotrophin-releasing hormone, Urocortin, cardiac ischaemia and reperfusion injury, Affymetrix gene chip microarrays, affective disorders, cardiomyocyte mitochondria
Abstract: The study of the Urocortin family of peptides is becoming increasingly important clinically, as new discoveries have revealed that their roles in the body are extremely diverse. They range from being involved in the aetiology of affective disorders, boosting the immune system, to cardioprotection during ischaemia and reperfusion injury. Therefore, it is important to understand how these peptides become activated, how they activate different cell types and finally their intracellular signalling pathways. Such studies may enable scientists to develop clinical therapies based on their mechanism of action, which may be used to alleviate a diverse range of pathologies.
Export Options
About this article
Cite this article as:
M. Lawrence K. and S. Latchman D., The Urocortins: Mechanisms of Cardioprotection and Therapeutic Potential, Mini-Reviews in Medicinal Chemistry 2006; 6 (10) . https://dx.doi.org/10.2174/138955706778560111
DOI https://dx.doi.org/10.2174/138955706778560111 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oxytocin in the Heart Regeneration
Recent Patents on Cardiovascular Drug Discovery Hyperthermia: From Diagnostic and Treatments to New Discoveries
Recent Patents on Biotechnology Survival and Migration of Pre-induced Adult Human Peripheral Blood Mononuclear Cells in Retinal Degeneration Slow (rds) Mice Three Months After Subretinal Transplantation
Current Stem Cell Research & Therapy Inflammation in Cardiovascular Disease and Regulation of the Actin Cytoskeleton in Inflammatory Cells: The Actin Cytoskeleton as a Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Gene Therapy in Cerebrovascular Diseases
Current Gene Therapy Recent Developments in Drug Design of NO-donor Hybrid Compounds
Mini-Reviews in Medicinal Chemistry Immunophilins and Cardiovascular Complications
Current Medicinal Chemistry Strain and Strain Rate Imaging by Echocardiography - Basic Concepts and Clinical Applicability
Current Cardiology Reviews Kinins and Cardiovascular Diseases
Current Pharmaceutical Design MicroRNA-34a Promotes Cardiomyocyte Apoptosis Post Myocardial Infarction Through Down-regulating Aldehyde Dehydrogenase 2
Current Pharmaceutical Design Anesthetic Pharmacology and Perioperative Considerations for the End Stage Liver Disease Patient
Current Clinical Pharmacology The Molecular Basis of Conantokin Antagonism of NMDA Receptor Function
Current Drug Targets Normobaric Hyperoxia Preconditioning Induces Changes in the Brain Lipidome
Current Neurovascular Research Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling
Current Pharmaceutical Design Phytochemicals as Adjunctive with Conventional Anticancer Therapies
Current Pharmaceutical Design Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis
Current Stem Cell Research & Therapy Recent Advances in Ethnopharmacological and Toxicological Properties of Bioactive Compounds from <i>Aloe barbadensis</i> (Miller), <i>Aloe vera</i>
Current Bioactive Compounds Diabetes and Its Complications: Therapies Available, Anticipated and Aspired
Current Diabetes Reviews HDL Therapy for the Treatment of Cardiovascular Diseases
Current Vascular Pharmacology Potential Therapeutic Properties of Natural Products Through the Expression of Heme Oxygenase-1
Mini-Reviews in Organic Chemistry